Skip navigation

Partnering to Defeat Cancer

07:30 - 10:30

Royal Society of Chemistry, Burlington House, Piccadilly, Mayfair, London W1J 0BA
03 July 2018

Join ICR Chief Executive Professor Paul Workman, Director of Enterprise Dr Angela Kukula, and ICR researchers and clinicians to learn more about our cuting-edge research, our culture of collaboration with industry and recent examples of success and upcoming opportunities.

Hear about the benefits of cross-organisational working to both academia and industry in talks from Tony Jones, CEO of One Nucleus – the international life science and healthcare industry membership organisation, and from Tom Heightman, Head of Chemistry at Astex Pharmaceuticals.

Most importantly, the morning will provide an opportunity to start conversations about how we can mutually share expertise to progress the discovery and development of potential cancer drugs and technologies to improve the lives of cancer patients and their families.


07.30 -  Registration and buffet breakfast

08.00 -  Welcome & Breakfast Briefing  

- Prof. Paul Workman, Chief Executive. ICR                                                    

08.35 -  ICR Quick-fire Showcase:

- with Prof. Kevin Harrington, Dr Bissan Al-Lazikani, Dr. Chris Bakal, Dr. Alessandro Vannini

09.15 -  Coffee break and networking

09.35 -  Working with the ICR – Astex Pharmaceuticals

- Dr Tom Heightman, Head of Chemistry, Astex Pharmaceuticals

09.55 -  ICR Capabilities Overview   

- Dr Angela Kukula, Director of Enterprise, ICR

10.10 -  The Importance of the Business/Academic Relationship

- Dr. Tony Jones, CEO, One Nucleus

10.25 -  Closing Remarks and Thanks

- Dr Angela Kukula, Director of Enterprise, ICR

10.30 -  Event Finishes and Networking opportunity

This event is free, but places are limited. Please register on-line to guarantee your place.

Title: Partnering to Defeat Cancer
Start: 2018-07-03 07:30:00Z
End: 2018-07-03 10:30:00Z